Previous Close | 1.1600 |
Open | 1.1600 |
Bid | 1.2200 x 800 |
Ask | 1.2300 x 1400 |
Day's Range | 1.1400 - 1.2500 |
52 Week Range | 1.0700 - 16.0000 |
Volume | |
Avg. Volume | 700,311 |
Market Cap | 502.121M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2420 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.50 |
PALO ALTO, Calif. & LONDON, May 12, 2022--Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or "the Company"), one of the world’s fastest growing digital healthcare companies, today announced its financial and operating results for the first quarter ended March 31, 2022.
PALO ALTO, Calif. & LONDON, May 09, 2022--Babylon (NYSE: BBLN) today announced that Ali Parsa, Founder and Chief Executive Officer, and Charlie Steel, Chief Financial Officer, will participate in the Bank of America Securities 2022 Healthcare Conference including a fireside chat between Ali Parsa and Allen Lutz, CFA at 9:20 a.m. PT on Thursday, May 12, 2022.
PALO ALTO, Calif. & LONDON, April 25, 2022--Babylon Holdings Limited (NYSE:BBLN) ("Babylon") notes the movement in its share price on April 22, 2022, with over 45x the average daily trading volume seen since its NYSE listing on October 22, 2021, concurrent with the expiry of Babylon’s 6-month lock-up of approximately 230,000,000 shares following its listing.